https://www.linkedin.com/jobs/view/3854133248
Radiochemist (Alpha)
We are seeking a skilled and experienced Targeted Alpha Therapy (TAT) radioisotope Radiochemist to join our research and innovation team. The ideal candidate will have a strong hands-on, research background in radiochemistry with a focus on alpha-emitting isotopes e.g. Actinium-225, Lead-212 and Astatine-211. The Alpha Radiochemist will be responsible for designing, implementing, and overseeing experiments involving alpha radioisotopes, as well as analyzing and interpreting the results. This will involve radiochemistry work in the lab to produce & evaluate novel drug candidates, supporting colleagues or collaborators producing alpha radioisotopes and assisting the Dir of TAT to manage preclinical projects conducted with external collaborators in Europe and globally. This position requires expertise in handling alpha-emitting materials and a deep understanding of the principles of nuclear chemistry and radiochemistry. This position is fixed-term position for 1 year.
- Forums
- ASX - By Stock
- Understanding Telix
https://www.linkedin.com/jobs/view/3854133248Radiochemist...
-
- There are more pages in this discussion • 1,127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.39 |
Change
-0.580(2.77%) |
Mkt cap ! $6.824B |
Open | High | Low | Value | Volume |
$20.56 | $20.81 | $20.39 | $10.34M | 504.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1057 | $20.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.41 | 31 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1057 | 20.390 |
1 | 4820 | 20.380 |
2 | 2000 | 20.350 |
2 | 17305 | 20.340 |
1 | 400 | 20.330 |
Price($) | Vol. | No. |
---|---|---|
20.410 | 31 | 1 |
20.570 | 6506 | 3 |
20.580 | 5879 | 3 |
20.610 | 12485 | 1 |
20.620 | 4820 | 1 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |